Impact of MenBvac, an outer membrane vesicle (OMV) vaccine, on the meningococcal carriage. - Archive ouverte HAL Access content directly
Journal Articles Vaccine Year : 2013

Impact of MenBvac, an outer membrane vesicle (OMV) vaccine, on the meningococcal carriage.

(1, 2) , (1, 2) , (1, 3) , (4) , (5) , (1) , (1) , (5) , (5) , (1, 2)
1
2
3
4
5

Abstract

The aim of the study was to analyze the impact of MenBvac, an outer membrane vesicle (OMV) vaccine against P1.7,16 strains, on meningococcal carriage. During a B:14:P1.7,16/ST-32 outbreak in Normandy (France), children aged 1-7 years were randomly selected to participate in the study. Among the 1082 volunteers, there were 17 Neisseria meningitidis carriers (carriage rate of 1.57%). MenBvac vaccination appeared associated with lower carriage rate, i.e., 0.31% among the vaccinated children versus 2.10% among the non-vaccinated (p=0.03). The beneficial effect on carriage was observed regardless of the strain serogroup. OMV-vaccinated mice also showed reduction of bacterial acquisition of OMV-homolog and hererolog strains in respiratory pathways after intranasal challenge. These results suggest that meningococcal OMV-based vaccines reduce meningococcal carriage and may hence confer herd immunity.
Not file

Dates and versions

pasteur-02073842 , version 1 (20-03-2019)

Identifiers

Cite

Valérie Delbos, Ludovic Lemée, Jacques Benichou, Gilles Berthelot, Ala-Eddine Deghmane, et al.. Impact of MenBvac, an outer membrane vesicle (OMV) vaccine, on the meningococcal carriage.. Vaccine, 2013, 31 (40), pp.4416-4420. ⟨10.1016/j.vaccine.2013.06.080⟩. ⟨pasteur-02073842⟩
66 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More